Does APIXABAN Cause International normalised ratio increased? 317 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 317 reports of International normalised ratio increased have been filed in association with APIXABAN (ELIQUIS). This represents 0.2% of all adverse event reports for APIXABAN.
317
Reports of International normalised ratio increased with APIXABAN
0.2%
of all APIXABAN reports
30
Deaths
172
Hospitalizations
How Dangerous Is International normalised ratio increased From APIXABAN?
Of the 317 reports, 30 (9.5%) resulted in death, 172 (54.3%) required hospitalization, and 33 (10.4%) were considered life-threatening.
Is International normalised ratio increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APIXABAN. However, 317 reports have been filed with the FAERS database.
What Other Side Effects Does APIXABAN Cause?
Death (18,501)
Cerebrovascular accident (7,237)
Atrial fibrillation (5,690)
Off label use (5,590)
Thrombosis (5,298)
Fall (5,063)
Cardiac disorder (4,917)
Haemorrhage (4,770)
Dyspnoea (4,379)
Gastrointestinal haemorrhage (4,030)
What Other Drugs Cause International normalised ratio increased?
WARFARIN (5,622)
RIVAROXABAN (863)
ACETAMINOPHEN (533)
ASPIRIN (448)
CLOPIDOGREL BISULFATE (314)
FLUINDIONE (286)
AMIODARONE (277)
FUROSEMIDE (277)
DABIGATRAN ETEXILATE (223)
ENOXAPARIN (217)
Which APIXABAN Alternatives Have Lower International normalised ratio increased Risk?
APIXABAN vs APOMORPHINE
APIXABAN vs APRACLONIDINE
APIXABAN vs APREMILAST
APIXABAN vs APREPITANT
APIXABAN vs APROTININ